Cancer Immunotherapy Congress

1 post / 0 new
Ajay Nimbalkar
Ajay Nimbalkar's picture
Cancer Immunotherapy Congress

Over the past several years, cancer immunotherapy has made extraordinary progress both conceptually and in clinical practice. A variety of strategies are continuing to evolve in the laboratory and in the clinic, including cancer vaccines, T cells, and immune checkpoint blockade. The Cancer Immunotherapy Congress to be held on 19 - 20 May 2016 in Boston, USA will present these ongoing challenges along with some recent technological advances.